연구동향 분석

Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma

김승업 신동현 이재승 전영은 김범경 박준용 김도영 안상훈 한광협 강원석 최문석 곽금연 백용한 이준혁 고광철 백승운 김휘영 김태헌 유권 하연정 김미나 이주호 황성규 김순선 조효정 정재연 조성원 박승하 허내윤 홍영미 윤기태 조몽 박정길 강민규 박수영 권영오 탁원영 장세영 2021년

논문상세정보
인용/피인용
' Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • alpha fetoprotein
  • carcinoma
  • hepatocellular
  • prognosis
  • transarterial chemoembolization
  • treatment outcome
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
811 0

0.0%

' Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma' 의 참고문헌

  • Transarterial chemoembolization versus resection for the intermediate stage hepatocellular carcinoma
    김준영 [2016]
  • Transarterial chemoembolization in treatment-naïve and recurrent hepatocellular carcinoma : a propensity-matched outcome analysis
    Kim DS [2019]
  • The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
    김정희 [2017]
  • Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
  • Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma
    Kim N [2019]
  • Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells : characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc
    Mazure NM [2002]
  • Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
    Kim DY [2012]
  • Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Lee YK [2013]
  • Prognostic role of serial alpha-fetoprotein levels in hepatocellular carcinoma treated with locoregional therapy
    Paul SB [2019]
  • Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern
    Gao F [2016]
  • Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : a response-based approach
    Han G [2020]
  • Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma: a meta-analysis
    He C [2019]
  • Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma : CT-pathologic correlation in 178 liver explants
  • MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma
    Kloeckner R [2010]
  • Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
    Kim MN [2019]
  • Hepatocellular carcinoma
    Forner A [2018]
  • Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
    Park Y [2019]
  • Evolving strategies for the management of intermediatestage hepatocellular carcinoma : available evidence and expert opinion on the use of transarterial chemoembolization
    Raoul JL [2011]
  • Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma : considerations for tumor response assessment
    Kim MN [2015]
  • Early prediction of the outcome using tumor markers and mRECIST in unresectable hepatocellular carcinoma patients who underwent transarterial chemoembolization
    Ichikawa T [2016]
  • EASL Clinical Practice Guidelines : management of hepatocellular carcinoma
  • Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
    Kim CG [2019]
  • Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C
    Chun HS [2020]
  • Current strategy for staging and treatment : the BCLC update and future prospects
    Forner A [2010]
  • Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma
    Abbasi A [2012]
  • Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
    Kim BK [2015]
  • Comparison of α-fetoprotein criteria and modified response evaluation criteria in solid tumors for the prediction of overall survival of patients with hepatocellular carcinoma after transarterial chemoembolization
    Zhang YQ [2018]
  • Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
    Lim TS [2016]
  • Clinical significance of alpha-fetoprotein : involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma
  • Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization
    He C [2017]
  • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma : a randomised controlled trial
    Llovet JM [2002]
  • Applicability of BCLC stage for prognostic stratification in comparison with other staging systems : single centre experience from longterm clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma
    Kim BK [2012]
  • Alpha-fetoprotein response following transarterial chemoembolization indicates improved survival for intermediate-stage hepatocellular carcinoma
    Liu G [2019]
  • Alpha-fetoprotein assessment for hepatocellular carcinoma after transarterial chemoembolization
    Tian M [2019]
  • Alpha-fetoprotein : the predictor of microvascular invasion in solitary small hepatocellular carcinoma and criterion for anatomic or non-anatomic hepatic resection
    Fan LF [2013]
  • Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score
    Park Y [2016]
  • A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
  • A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world : 2010-2016
    Yu SJ [2016]
  • 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma